Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Moon launches are having a moment. But can you make money off the lunar frenzy?
Consumer confidence improves in March as brighter job-market view outweighs surging costs amid Iran war
20 stocks that bucked the stock market’s decline in March with double-digit gains
CoreWeave’s stock rises as investors cheer unique financing deal
Pension funds could ride to the stock market’s rescue as retail investors step back
Snowflake’s stock falls as investors weigh a surprise leadership shift
These 20 stocks in the S&P 500 fell hardest during March
Apple turns 50. Here’s how it can shake its midlife crisis.
Marvell’s stock soars. What’s behind the new Nvidia investment and partnership.
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
It’s time to get defensive, say Morgan Stanley strategists. Hold more cash and make these moves.
Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases
Moon launches are having a moment. But can you make money off the lunar frenzy?
Consumer confidence improves in March as brighter job-market view outweighs surging costs amid Iran war
20 stocks that bucked the stock market’s decline in March with double-digit gains
CoreWeave’s stock rises as investors cheer unique financing deal
Pension funds could ride to the stock market’s rescue as retail investors step back
Snowflake’s stock falls as investors weigh a surprise leadership shift
These 20 stocks in the S&P 500 fell hardest during March
Apple turns 50. Here’s how it can shake its midlife crisis.
Marvell’s stock soars. What’s behind the new Nvidia investment and partnership.
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
It’s time to get defensive, say Morgan Stanley strategists. Hold more cash and make these moves.
Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases
How this 34-year-old went from working in retail to owning her own restaurant
9-10-24
Jackie Podhurst worked for Target and Macy’s before opening a restaurant in New Jersey.
Share this on:
